Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab and methotrexate in moderate to severe rheumatoid arthritis
NCT01878318Phase 4Withdrawn
- Sponsor
- Roche
- Start
- Jun 2013
- Primary completion
- Jun 2015
01
Overview
Phase 4, open-label, single-arm trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Primary endpoint: Change in extent and degree of synovitis in the hand assessed by MRI according to the OMERACT RAMRIS scale at 24 weeks. Planned start Jun 2013; status: withdrawn.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01878318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878318.